Over the last several decades, the clinical research industry has been riddled with the challenge of meeting enrollment goals on time. Eighty percent of trials fall short of their goals. Moreover, the industry is further challenged with maintaining trial participation by patients once they are enrolled.…
With patient attrition rates in clinical trials on the rise, retention strategies and tools must be constantly refreshed, refined, and even invented. Truly patient-centric approaches to aid retention are called for. How about a tool that puts the study right in the patient’s hands? Specifically…
This is the second in our Patient Centricity blog series. Read the first blog in the series, “What Does Patient Centricity Really Mean?” Pharmaceutical, biotech, medical device, and private medical facilities have been conducting clinical trials for decades, and over the years, the “bar” for medical…
Patient centricity is officially defined as the process of designing a service or solution around the patient. Sounds simple enough, right? For those of us in the clinical research space, it’s not always as simple as it would seem. The cultural mindset has to realign…
In June, I attended the Avoca Consortium summit in Dublin on behalf of Imperial. Representatives from more than 40 companies working in pharma and biotech attended, which was quite an achievement, especially considering that many of the delegates were juggling projects between major industry gatherings…